Elina Tzvetanova
Overview
Explore the profile of Elina Tzvetanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimitrova L, Mileva M, Georgieva A, Tzvetanova E, Popova M, Bankova V, et al.
Plants (Basel)
. 2025 Jan;
14(2).
PMID: 39861566
is an opportunistic pathogen that causes nosocomial infections of the urinary tract, upper respiratory tract, gastrointestinal tract, central nervous system, etc. It is possible to develop bacteremia and sepsis in...
2.
Gerzilov V, Alexandrova A, Petrov P, Boncheva V, Keranova N, Andreeva M, et al.
Animals (Basel)
. 2022 Oct;
12(19).
PMID: 36230391
This study aimed to assess the changes in the oxidative status of six genotypes of free-range laying hens during cold, thermoneutral, and hot periods by measuring the levels of lipid...
3.
Dragomanova S, Lazarova M, Munkuev A, Suslov E, Volcho K, Salakhutdinov N, et al.
Molecules
. 2022 Sep;
27(17).
PMID: 36080227
Methods: Scopolamine (Scop) was applied intraperitoneally in Wistar rats for 11 days, simultaneously with MACs or M as a referent, respectively. Brain acetylcholine esterase (AChE) activity, noradrenaline and serotonin levels,...
4.
Vilhelmova-Ilieva N, Petrova Z, Georgieva A, Tzvetanova E, Trepechova M, Mileva M
Life (Basel)
. 2022 Jul;
12(7).
PMID: 35888176
The use of various herbal therapists as part of traditional medicine in different parts of the world, including Bulgaria, is due to the knowledge accumulated over the centuries by people...
5.
Tancheva L, Lazarova M, Velkova L, Dolashki A, Uzunova D, Minchev B, et al.
J Alzheimers Dis
. 2022 May;
88(1):155-175.
PMID: 35599481
Background: Alzheimer's disease (AD) is a complex neurodegenerative disease with multifactorial etiology, unsatisfactory treatment, and a necessity for broad-spectrum active substances for cure. The mucus from Helix aspersa snail is...
6.
Dragomanova S, Pavlov S, Marinova D, Hodzev Y, Petralia M, Fagone P, et al.
Antioxidants (Basel)
. 2022 Feb;
11(2).
PMID: 35204256
There is growing attention on natural substances capable of stimulating the cholinergic system and of exerting antioxidant effects, as potential therapeutic agents in Alzheimer's disease (AD). The aim of the...
7.
Lazarova M, Tancheva L, Chayrov R, Tzvetanova E, Alexandrova A, Popatanasov A, et al.
J Mol Neurosci
. 2022 Jan;
72(4):900-909.
PMID: 35091981
The neuroprotective capacity of newly synthesized amantadine derivative tyrosinyl-amantadine (Tyr-Am) with expected antiparkinsonian properties was evaluated in a 6-hydroxydopamine (6-OHDA) model of Parkinson's disease. Male Wistar rats were divided into...
8.
Vircheva S, Nenkova G, Georgieva A, Alexandrova A, Tzvetanova E, Mateeva P, et al.
Cell Biochem Funct
. 2011 Sep;
30(1):18-23.
PMID: 21953526
The pathogenesis of many diseases and different pathological conditions, including inflammation, is associated with excess production of reactive oxygen species (ROS). The present study aimed to investigate the effects of...
9.
Tzvetanova E, Nenkova G, Georgieva A, Alexandrova A, Girchev R, Kirkova M
Cell Biochem Funct
. 2011 Feb;
29(2):135-41.
PMID: 21287579
The in vivo effects of nociceptin (N/OFQ(1-13)NH(2) ) and its structural analogues ([Dab(9) ]N/OFQ(1-13)NH(2) , [Dap(9) ]N/OFQ(1-13)NH(2) and [Cav(9) ]N/OFQ(1-13)NH(2) ) on the levels of lipid peroxidation and cell antioxidants...
10.
Kirkova M, Tzvetanova E, Vircheva S, Zamfirova R, Grygier B, Kubera M
Cell Biochem Funct
. 2010 Aug;
28(6):497-502.
PMID: 20803706
In vivo effects of the antidepressant fluoxetine on spleen antioxidant status of C57BL/6 mice were studied using a melanoma experimental model. After a 14-day treatment with fluoxetine (10 mg kg(-1)...